Daiichi Sankyo

This study tested a targeted drug called trastuzumab deruxtecan for adults with advanced non-small cell lung cancer that has a specific genetic change (a HER2 mutation) and had worsened after prior platinum-based chemotherapy. The goal was to see if the drug could shrink tumors a…

This study observed how well the blood-thinning medication edoxaban worked and how safe it was for preventing strokes in Korean patients aged 80 and older who had atrial fibrillation. Doctors followed over 1,200 patients for up to a year after they were prescribed the drug as par…

This study tested how well and how safely the cholesterol-lowering drug bempedoic acid works for people in Taiwan. It involved about 180 adults with high cholesterol who were not reaching their target cholesterol levels with their current medications. The main goal was to see how…

This study tested if a new single pill containing three cholesterol-lowering drugs works the same way in the body as taking the three drugs separately. It involved 58 healthy adult volunteers to compare how the body absorbs and processes the medications. The goal is to see if the…

This study tested an experimental drug called trastuzumab deruxtecan for people with advanced colorectal cancer that has a specific genetic feature called HER2-overexpression. The 122 participants had cancer that had spread and had already tried standard treatments. The main goal…

This study tested an experimental drug called DS-1062a for people with advanced non-small cell lung cancer that had specific genetic changes. The 137 participants had already tried targeted therapies and chemotherapy that stopped working for them. Researchers measured how well th…

This study tested whether a new single pill containing three cholesterol-lowering drugs works the same way in the body as taking the three separate pills together. It involved 58 healthy adult volunteers to compare how the body absorbs and processes the medications. The goal is t…

This study tested whether a new targeted drug called trastuzumab deruxtecan (DS-8201a) works better than standard treatments for people with advanced HER2-positive breast cancer that has spread and stopped responding to a previous targeted therapy. It involved 608 adults whose ca…

This study tested if a new single pill containing three cholesterol-lowering drugs works the same way in the body as taking the three drugs as separate pills. It involved 58 healthy adult volunteers to measure how the body absorbs and processes the medications. The goal is to see…

This study analyzed real-world treatment patterns and outcomes for patients with advanced HR-positive, HER2-negative breast cancer who progressed after first-line hormone therapy. Researchers examined medical records of 1,415 patients to understand how long different second-line …

This study tested if a new single pill containing three cholesterol-lowering drugs works the same in the body as taking the three drugs as separate pills. It involved 58 healthy adult volunteers to measure how the body absorbs the medications. The goal is to see if the combined p…

This study aims to understand how common a specific protein marker called HER2 is in recurrent advanced endometrial, ovarian, and cervical cancers in Taiwan. Researchers will look back at the medical records and tissue samples of about 509 patients to see how many have high level…